Clinical TrialID 8471
Urolithin A Supplementation in Middle-aged Adults With Obesity
NCT05921266
Obesity|Vascular Dementia|Cognitive Impairment
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8471
- Evidence Id
- 8471
- Core Evidence Id
- 8471
- Source Clinical Trial Id
- 8469
- Herb2 Clinical Trial Id
- HBCT008469
- Nct Id
- NCT05921266
- Title
- Urolithin A Supplementation in Middle-aged Adults With Obesity
- Status
- Recruiting
- Phase
- Study Result
- No
- Study Condition
- Obesity|Vascular Dementia|Cognitive Impairment
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
- Intervention
- DIETARY_SUPPLEMENT: Urolithin A|OTHER: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Triple
- Intervention Purpose
- Basic_Science
- Gender
- All
- Age
- Adult
- Enrollment
- 54
- Outcome Measure
- Change in arterial function and local stiffness, Flow-mediated dilation, Baseline (day 0) and endpoint (day 28)
- Sponsor Collaborator
- University of Oklahoma
- Funded By
- OTHER
- Location
- Translational GeroScience Laboratory - O'Donoghue Research Building, Oklahoma City, Oklahoma, 73117, United States
- Other Id
- UA15561
- Start Date
- 2023-11-21
- Primary Completion Date
- 2024-12
- Completion Date
- 2025-05
- First Posted
- 2023-06-27
- Results First Posted
- Last Update Posted
- 2024-02-29
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05921266
- Title Cn
- Title En
- Urolithin A Supplementation in Middle-aged Adults With Obesity
- Bilingual Status
- semi_complete